Esthesioneuroblastoma Treated with External Radiotherapy. Case Report
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Esthesioneuroblastoma is a rare tumour arising from the olfactory epithelium of the nasal vault which frequently invades the cranial base and orbit. Esthesioneuroblastoma has a bimodal age distribution between 11 and 20 years and between 51 and 60 years. Esthesioneuroblastoma accounts for approximately 1-5% of intranasal cancers. The case is reported of a 79-year-old female patient with a Kadish stage C tumour with a one-year history of headache, nasal obstruction, anosmia, rhinorrhoea and epistaxis. Aim of this study is to analyse the natural history, treatment and prognosis of this tumour, based on a review of the literature.
References
1.
Chao K, Kaplan C, Simpson J, Haughey B, Spector G, SESSIONS D
. Esthesioneuroblastoma: the impact of treatment modality. Head Neck. 2001; 23(9):749-57.
DOI: 10.1002/hed.1107.
View
2.
Broich G, Pagliari A, Ottaviani F
. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res. 1997; 17(4A):2683-706.
View
3.
Gondim J, Ramos Jr F, Azevedo J, Carrero Jr F, Tella Jr O
. Esthesioneuroblastoma: case report. Arq Neuropsiquiatr. 2002; 60(2-A):303-7.
DOI: 10.1590/s0004-282x2002000200024.
View
4.
Gruber G, Laedrach K, Baumert B, Caversaccio M, Raveh J, Greiner R
. Esthesioneuroblastoma: irradiation alone and surgery alone are not enough. Int J Radiat Oncol Biol Phys. 2002; 54(2):486-91.
DOI: 10.1016/s0360-3016(02)02941-3.
View
5.
Theilgaard S, Buchwald C, Ingeholm P, Kornum Larsen S, Eriksen J, Sand Hansen H
. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000. Acta Otolaryngol. 2003; 123(3):433-9.
DOI: 10.1080/00016480310001295.
View